Pure Biologics SA

PQB

Company Profile

  • Business description

    Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

  • Contact

    ul. Dunska 11
    Wroclaw54-427
    POL

    T: +48 570002829

    http://www.purebiologics.pl

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    6

Stocks News & Analysis

stocks

Oracle earnings: Solid execution secures revenue target and mitigates investor concerns

We raise our fair value estimate for Oracle stock.
stocks

US dividend shares are getting a boost from the HALO trade. Can it last?

Both high-dividend stocks and dividend-growth stocks are outperforming amid AI disruption.
stocks

Unconventional wisdom: A modern day bank run

Is the economy and investor portfolios at risk from a potential ‘bank run’ in private credit?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,839.1026.300.30%
CAC 407,911.53145.83-1.81%
DAX 4023,447.29142.36-0.60%
Dow JONES (US)46,558.47119.38-0.26%
FTSE 10010,261.1544.00-0.43%
HKSE25,465.60251.16-0.98%
NASDAQ22,105.36206.62-0.93%
Nikkei 22553,819.61633.35-1.16%
NZX 50 Index13,187.3411.95-0.09%
S&P 5006,632.1940.43-0.61%
S&P/ASX 2008,617.1029.200.34%
SSE Composite Index4,095.4533.65-0.82%

Market Movers